About infectious disease testing
Infectious diseases are caused by microorganisms such as viruses, bacteria, fungi, and parasites. Infectious diseases are one of the primary contributors to morbidity and mortality worldwide. According to the CDC, in the US there are more than 1.2 million people living with HIV infection and one in eight are unaware about their condition. In 2013, it was estimated that 47,352 Americans were diagnosed with HIV infection and in the same year 26,688 people were diagnosed with AIDS. Early diagnosis and treatment play an important role to prevent the long-term complications of HIV/AIDS. Molecular testing, POCT, and immunodiagnostics are used for the screening and detection the disease. Infectious diseases increasingly threaten public health and contribute significantly to the rising costs of health care.
Manufacturers are developing diagnostic tests that can provide results in just a few minutes. For example, Alere developed Alere BinaxNOW Influenza A&B Card, which can detect influenza A & B in 15 minutes.
Technavio's analysts forecast the infectious disease testing market in the US to grow at a CAGR of 5.81% over the period 2014-2019.
Covered in this report
The report covers the current scenario and the growth prospects of the infectious disease testing market in the US for the period of 2015-2019. To calculate the market size, we consider the revenue generated from the sales of equipment and consumables from molecular diagnostics, POCT diagnostic devices, and immunodiagnostics, which are used to detect infectious diseases:
The market is segmented based on technology:
- Molecular diagnostic test
- POCT
- Immunodiagnostic test
The POCT for infectious disease is further segmented based on application:
- HIV
- Respiratory
- HAIs
- Sexual health
- Tropical diseases
- Hepatitis
In addition, the market is segmented based on products:
Technavio's report, Infectious Disease Testing Market in the US 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report presents the vendor landscape and a corresponding detailed analysis of the five key vendors in the market. The vendor landscape focuses on vendors that provide access to new technologies. The report also outlines the challenges faced by vendors and the market at large, as well as the key trends emerging in the market.
Key vendors
- Abbott Diagnostics
- Alere
- Beckman Coulter Diagnostics
- Roche
- Siemens Healthcare
Other prominent vendors
- Abaxis
- Acon Laboratories
- Avioq
- BD
- Bio-Rad Laboratories
- Cavidi
- Cepheid
- Chembio Diagnostic Systems
- Clarity Diagnostics
- EMD Millipore
- Epitope Diagnostic
- Gold Standard Diagnostics
- Hologic
- Immunetics
- InBios International
- Life Technologies
- Maxim Biomedical
- Mindray
- OraSure Technologies
- Ortho Clinical Diagnostics
- Quidel Corporation
- Thermo Fisher Scientific
- Trinity Biotech
Market driver
- North America free trade agreement
- For a full, detailed list, view our report
Market challenge
- Medical device excise tax law
- For a full, detailed list, view our report
Market trend
- Development of innovative diagnostics initiatives
- For a full, detailed list, view our report
Key questions answered in this report
- What will the market size be in 2019 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
Table of Contents
PART 01: Executive summary
PART 02: Scope of the report
- Market overview
- Top-vendor offerings
PART 03: Market research methodology
- Research methodology
- Economic indicators
PART 04: Introduction
PART 05: Market landscape
PART 06: Infectious disease landscape in the US
- Reimbursement in US
- Clinical laboratory improvement amendments (CLIA) waiver from US Food and Drug Administration
- Five forces analysis
PART 07: Market segmentation by technology
- Molecular diagnostic test
- POCT for infectious diseases
- Immunodiagnostic tests
PART 08: Market segmentation by application
PART 09: Market segmentation by product
PART 10: Market drivers
- NAFTA
- Demand for rapid and automated diagnostics
- Shift toward patient-centered model
- Focus on disease management
PART 11: Impact of drivers
PART 12: Market challenges
- Medical device excise tax law
- Increase in globalization
- New microbial diseases
PART 13: Impact of drivers and challenges
PART 14: Market trends
- Development of innovative diagnostics initiatives
- Key role of US Army Medical Research Institute in Diagnostics and Development (USAMRIID)
- Low-cost microfluidic devices for POCT
- Focus on early diagnosis of infectious diseases
PART 15: Vendor landscape
- Competitive scenario
- Abbott Diagnostics
- Alere
- Roche Diagnostics
- Siemens Healthcare
- Beckman Coulter Diagnostics
- Other prominent vendors
PART 16: Key vendor analysis
- Abbott Diagnostics
- Alere
- Beckman Coulter
- Roche Diagnostics
- Siemens Healthcare
PART 17: Appendix
PART 18: Explore Technavio